Skip to content
PharmaInsight

Emtricitabine/Rilpivirine/Tenofovir alafenamide vs Oseltamivir phosphate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated January 2026

Oseltamivir phosphate was dispensed 433.5× as often as Emtricitabine/Rilpivirine/Tenofovir alafenamide in January 2026 — 867 items versus 2 in England.

2items

Emtricitabine/Rilpivirine/Tenofovir alafenamide · January 2026

NHSBSA Prescription Cost Analysis

867items

Oseltamivir phosphate · January 2026

NHSBSA Prescription Cost Analysis

Figure 1. Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Oseltamivir phosphate: national items dispensed by month

▬ Emtricitabine/Rilpivirine/Tenofovir alafenamide   ·   ╌ Oseltamivir phosphate

Oseltamivir phos… 2

Source: NHSBSA Prescription Cost Analysis, to January 2026

Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Oseltamivir phosphate, January 2026
Measure Emtricitabine/Rilpivirine/Tenofovir alafenamide Oseltamivir phosphate
Items, January 2026 2 867
Items, last 12 months 2 38,013
Net ingredient cost, January 2026 £771 £13,394

See the full profile for Emtricitabine/Rilpivirine/Tenofovir alafenamide or Oseltamivir phosphate.